Karoline V Gleixner

5PUBLICATIONS
67CO-AUTHORS
Gene and molecular therapyHaematological tumoursRespiratory diseasesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 22, 2025
Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.

Sonja Wurm, Jennifer M Moritz, Verena Petzer

|Jun 01, 2024
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.

Karin Bauer, Alexander Hauswirth, Karoline V Gleixner

|Jan 02, 2023
N-terminal pro-brain natriuretic peptide is a prognostic marker for response to intensive chemotherapy, early death, and overall survival in acute myeloid leukemia.

Irene Graf, Georg Greiner, Rodrig Marculescu

|Mar 30, 2021
Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms.

Klára Obrová, Silke Grumaz, Marlene Remely

|Feb 29, 2020
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification.

Jakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová

Pageof 1

Frequent Collaborators

5 joint publications

Wolfgang R Sperr

1 joint publications

Jakub Trizuljak

1 joint publications

Lucie Nekvindová

1 joint publications

Hanneke O Elberink